| Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases BNM Zordoky, IM Robertson, JRB Dyck Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (6 …, 2015 | 255 | 2015 |
| Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases BNM Zordoky, AOS El-Kadi Pharmacology & therapeutics 125 (3), 446-463, 2010 | 180 | 2010 |
| Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice VW Dolinsky, S Chakrabarti, TJ Pereira, T Oka, J Levasseur, D Beker, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (10 …, 2013 | 159 | 2013 |
| Role of NF-κB in the regulation of cytochrome P450 enzymes BNM Zordoky, AOS El-Kadi Current drug metabolism 10 (2), 164-178, 2009 | 154 | 2009 |
| H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart BNM Zordoky, AOS El-Kadi Journal of pharmacological and toxicological methods 56 (3), 317-322, 2007 | 118 | 2007 |
| Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice VW Dolinsky, KJ Rogan, MM Sung, BN Zordoky, MJ Haykowsky, ... American Journal of Physiology-Endocrinology and Metabolism 305 (2), E243-E253, 2013 | 111 | 2013 |
| Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats BNM Zordoky, ME Aboutabl, AOS El-Kadi Drug Metabolism and Disposition 36 (11), 2277-2286, 2008 | 100 | 2008 |
| Metabolomic fingerprint of heart failure with preserved ejection fraction BN Zordoky, MM Sung, J Ezekowitz, R Mandal, B Han, TC Bjorndahl, ... PloS one 10 (5), e0124844, 2015 | 96 | 2015 |
| Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats BNM Zordoky, A Anwar-Mohamed, ME Aboutabl, AOS El-Kadi Toxicology and applied pharmacology 242 (1), 38-46, 2010 | 91 | 2010 |
| The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and … BNM Zordoky, D Bark, CL Soltys, MM Sung, JRB Dyck Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (6), 1943-1957, 2014 | 86 | 2014 |
| Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver BNM Zordoky, A Anwar-Mohamed, ME Aboutabl, AOS El-Kadi Drug Metabolism and Disposition 39 (8), 1440-1450, 2011 | 72 | 2011 |
| Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure BNM ZORDOKY, AOS EL-KADI Current drug metabolism 9 (2), 122-128, 2008 | 65 | 2008 |
| 3‐Methylcholanthrene and benzo (a) pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats ME Aboutabl, BNM Zordoky, AOS El‐Kadi British journal of pharmacology 158 (7), 1808-1819, 2009 | 64 | 2009 |
| Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation A Anwar-mohamed, BNM Zordoky, ME Aboutabl, AOS El-Kadi Pharmacological research 61 (5), 410-418, 2010 | 48 | 2010 |
| AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism MM Sung, BN Zordoky, AL Bujak, JSV Lally, D Fung, ME Young, ... Cardiovascular research 107 (2), 235-245, 2015 | 47 | 2015 |
| Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells BNM Zordoky, AOS El-Kadi Vascular pharmacology 49 (4-6), 166-172, 2008 | 44 | 2008 |
| AMPK-dependent inhibitory phosphorylation of ACC is not essential for maintaining myocardial fatty acid oxidation BNM Zordoky, J Nagendran, T Pulinilkunnil, PC Kienesberger, G Masson, ... Circulation research 115 (5), 518-524, 2014 | 42 | 2014 |
| Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats AMS Alsaad, BNM Zordoky, AA El-Sherbeni, AOS El-Kadi Drug Metabolism and Disposition 40 (11), 2126-2135, 2012 | 41 | 2012 |
| Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline‐induced cardiac hypertrophy HN Althurwi, MMY Tse, G Abdelhamid, BNM Zordoky, BD Hammock, ... British journal of pharmacology 168 (8), 1794-1807, 2013 | 40 | 2013 |
| Role of cytochrome P450–mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy AMS Alsaad, BNM Zordoky, MMY Tse, AOS El-Kadi Drug metabolism reviews 45 (2), 173-195, 2013 | 39 | 2013 |
Jason DyckUniversity of AlbertaVerified email at ualberta.ca
